SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 122 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,936,638 | -34.2% | 7,993,963 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $46,993,272 | +84.2% | 7,884,777 | +1.1% | 0.00% | 0.0% |
| Q1 2023 | $25,511,973 | -17.0% | 7,801,827 | +0.2% | 0.00% | 0.0% |
| Q4 2022 | $30,752,136 | -26.4% | 7,785,351 | +11.9% | 0.00% | 0.0% |
| Q3 2022 | $41,762,000 | -7.2% | 6,960,457 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $44,979,000 | -15.9% | 6,995,329 | +8.1% | 0.00% | 0.0% |
| Q1 2022 | $53,451,000 | -42.2% | 6,470,876 | +8.4% | 0.00% | -50.0% |
| Q4 2021 | $92,426,000 | -19.5% | 5,970,703 | +17.1% | 0.00% | -33.3% |
| Q3 2021 | $114,822,000 | +221.8% | 5,098,670 | +180.9% | 0.00% | +200.0% |
| Q2 2021 | $35,682,000 | -40.1% | 1,814,891 | +2.0% | 0.00% | -50.0% |
| Q1 2021 | $59,556,000 | – | 1,779,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
| Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
| Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
| Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
| Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
| SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
| HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
| Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
| Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |